TMRW safeguards the world’s most precious cells for life. The TMRW platform revolutionizes the management, identification, and storage of fertility cells, replacing the manual and analog methods that have remained largely unchanged since IVF was first used in animal husbandry more than 50 years ago.
Developed in partnership with leading fertility doctors and embryologists, TMRW’s technology will play a central role in the births of tens of millions of people in the coming years by reducing the risk of loss or misidentification of the priceless cells used in IVF. Our automation eliminates error-prone manual tasks in the embryology lab, allowing embryologists to focus on the most skilled and technical aspects of their work. In 2021, TMRW ivfOS was recognized as one of Fast Company's World Changing Ideas in the Software Category.
The TMRW team includes many of the world’s most celebrated pioneers in clinical medicine, reproductive biology, embryology, and cryogenic biobanking who have synthesized their collective knowledge, vision, and experience in the development of the TMRW platform. We’ve brought together a diverse, cross-disciplinary team to achieve our mission — and we’re always looking for more innovators to join us in creating a better tomorrow.
Developed in partnership with leading fertility doctors and embryologists, TMRW’s technology will play a central role in the births of tens of millions of people in the coming years by reducing the risk of loss or misidentification of the priceless cells used in IVF. Our automation eliminates error-prone manual tasks in the embryology lab, allowing embryologists to focus on the most skilled and technical aspects of their work. In 2021, TMRW ivfOS was recognized as one of Fast Company's World Changing Ideas in the Software Category.
The TMRW team includes many of the world’s most celebrated pioneers in clinical medicine, reproductive biology, embryology, and cryogenic biobanking who have synthesized their collective knowledge, vision, and experience in the development of the TMRW platform. We’ve brought together a diverse, cross-disciplinary team to achieve our mission — and we’re always looking for more innovators to join us in creating a better tomorrow.
Location: United States, New York
Employees: 51-200
Total raised: $170M
Founded date: 2018
Investors 4
| Date | Name | Website |
| - | 5AM Ventur... | 5amventure... |
| 12.08.2021 | Leerink Tr... | transformc... |
| - | What If Ve... | whatif.vc |
| 30.07.2021 | GV | gv.com |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 25.07.2024 | Series D | $28M | - |
| 20.07.2021 | Series C | $105M | - |
| 18.12.2019 | Series B | $25M | 5AM Ventur... |
| 29.05.2019 | Series A | $12M | - |
Mentions in press and media 19
| Date | Title | Description |
| 27.07.2024 | TMRW Life Sciences: Pioneering the Future of Fertility Storage | In the realm of fertility treatments, the stakes are high. The management of frozen sperm, eggs, and embryos is not just a technical task; it’s a matter of life and hope. TMRW Life Sciences is stepping into this arena with a bold vision and... |
| 25.07.2024 | TMRW Life Sciences: Automated Specimen Management Company Secures Over $28 Million In Series D | TMRW Life Sciences (TMRW), the creator of the only FDA-cleared automated specimen management and storage platform for frozen human sperm, eggs, and embryos, announced that it closed a $28+ million Series D equity funding round to meet high ... |
| 21.07.2021 | TMRW Life Sciences Raises $105 Million to Accelerate Global Rollout of World’s First Automated Platform for IVF Egg & Embryo Management | - |
| 20.07.2021 | TMRW Life Sciences Closes $105M Series C | NEW YORK, NY, TMRW Life Sciences announces the completion of a $105 million Series C equity and debt financing today. >> Click here for more funding data on TMRW Life Sciences >> To export TMRW Life Sciences funding data to ... |
| 20.07.2021 | TMRW Life Sciences Raises $105 Million to Accelerate Global Rollout of World's First Automated Platform for IVF Egg & Embryo Management | |
| 20.07.2021 | TMRW Life Sciences Raises $105M in Funding | TMRW Life Sciences, Inc., a NYC-based life sciences technology company providing an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization (IVF), completed a $105m Series C equity ... |
| 05.03.2021 | TMRW Appoints Brian E. Miller, Ph.D., as SVP of Sales | |
| 12.01.2021 | TMRW Adds Three High Profile Hires To Its Senior Executive Team | |
| 18.12.2019 | Automated Embryology And Cryo-Management Company TMRW Raises $25 Million | TMRW Life Sciences, an integrated platform for automated software-guided embryology and cryo-management company, announced it raised $25 million TMRW Life Sciences — an integrated platform for automated software-guided embryology and cryo-m... |
| 17.12.2019 | TMRW Life Sciences Raises $25 Million in Series B Funding Led by 5AM Ventures | - |
Show more